Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2020-09-16 2020-09-15
Drug Identification Number 02314002 02314002
Brand name SANDOZ QUETIAPINE SANDOZ QUETIAPINE
Common or Proper name SANDOZ QUETIAPINE SANDOZ QUETIAPINE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients QUETIAPINE QUETIAPINE
Strength(s) 100MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code N05AH N05AH
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for discontinuation Raw material availability Raw material availability
Anticipated discontinuation date 2020-05-01 2020-05-01
Actual discontinuation date 2020-09-15 2020-09-15
Remaining supply date 2020-08-28 2020-08-28
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments